Drug intelligence / Profile preview

bacitracin zinc + lidocaine hydrochloride + polymyxin b sulfate + neomycin sulfate

Development stage
Approved
Lead developer
Trifecta Pharmaceuticals
Modality
Small Molecules
Administration
Topical
01

Overview

Bacitracin zinc + lidocaine hydrochloride + polymyxin b sulfate + neomycin sulfate is an over-the-counter topical combination product composed of three antibiotics plus a local anesthetic. Bacitracin inhibits bacterial cell wall synthesis, neomycin is an aminoglycoside antibiotic that inhibits bacterial protein synthesis, polymyxin B disrupts the outer membrane of susceptible gram-negative bacteria, and lidocaine provides local analgesia by blocking voltage-gated sodium channels. The combination is typically formulated as an ointment for first-aid use to help prevent infection and provide temporary pain relief in minor cuts, scrapes, and burns. Publicly listed marketed examples include Biotic-Plus and other store-brand triple-antibiotic-plus-lidocaine products marketed under the US OTC monograph framework rather than as a conventional novel prescription asset.

Brand names
Biotic-PlusRECELLTISTriple Antibiotic Plus Lidocaine
Other names
bacitracin zinc + neomycin sulfate + polymyxin b sulfate + lidocaine hydrochloridetriple antibiotic plus pain relieftopical triple antibiotic plus lidocaine
02

Targets

LPS (Lipopolysaccharide and associated Gram-negative outer membrane phospholipids)Bacterial RibosomeBacterial cell wall peptidoglycan biosynthesisSCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)

Beyond the preview

Go deeper on bacitracin zinc + lidocaine hydrochloride + polymyxin b sulfate + neomycin sulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bacitracin zinc + lidocaine hydrochloride + polymyxin b sulfate + neomycin sulfate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call